CRA and leading European payer experts hosted a 30-minute virtual webinar to explore how growing competitive dynamics are reshaping the rare diseases market across Europe.
Panelists:
Oriol Sola-Morales, Professor of Pharmacology and Health Economics, and former director of the Spanish Regional HTA Agency
Juergen Wasem, Professor of Health Services Management, and former chairperson of the German AMNOG Drug Price Arbitration Board
Entela Xoxi, Doctor of Pharmacology, and former coordinator of AIFA Patient Registries
Moderator:
Bhavesh Patel, Principal, Life Sciences Practice, Charles River Associates
